News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
627,380 Results
Type
Article (32008)
Company Profile (622)
Press Release (594750)
Section
Business (196000)
Career Advice (2101)
Deals (36029)
Drug Delivery (83)
Drug Development (77071)
Employer Resources (160)
FDA (15005)
Job Trends (14588)
News (329854)
Policy (28701)
Tag
Academia (1300)
Africa (666)
Alliances (46294)
Alzheimer's disease (1070)
Approvals (14945)
Arizona (108)
Artificial intelligence (64)
Asia (38825)
Australia (6303)
Bankruptcy (362)
Best Places to Work (10551)
Biotechnology (436)
C2C Services and Suppliers (70867)
California (1844)
Canada (897)
Cancer (364)
Career advice (1730)
Cell therapy (112)
China (133)
Clinical research (60717)
Collaboration (122)
Colorado (70)
Compensation (68)
Connecticut (67)
COVID-19 (2098)
Cystic fibrosis (68)
Data (213)
Diabetes (71)
Diagnostics (5926)
Drug pricing (62)
Earnings (79888)
Employer resources (135)
Europe (84134)
Events (104601)
Executive appointments (138)
FDA (15188)
Florida (216)
Funding (123)
Gene therapy (76)
Georgia (59)
GLP-1 (510)
Government (2852)
Healthcare (15893)
Hotbed/Location (436981)
Illinois (197)
Indiana (148)
Infectious disease (2120)
Inflammatory bowel disease (85)
Interviews (419)
IPO (16856)
Job creations (4197)
Job search strategy (1450)
Kansas (89)
Layoffs (452)
Legal (7084)
Lung cancer (86)
Manufacturing (88)
Maryland (306)
Massachusetts (1584)
Medical device (13172)
Medtech (13177)
Mergers & acquisitions (18998)
Metabolic disorders (230)
Michigan (131)
Minnesota (221)
Neuroscience (1210)
New Jersey (552)
New York (562)
NextGen Class of 2024 (5968)
Non-profit (2058)
North Carolina (644)
Northern California (771)
Obesity (137)
Ohio (90)
Opinion (213)
Patents (66)
Pennsylvania (546)
People (55233)
Pharmaceutical (119)
Phase I (19026)
Phase II (27149)
Phase III (20155)
Pipeline (105)
Postmarket research (1906)
Preclinical (7630)
Press Release (64)
Rare diseases (125)
Real estate (5695)
Recruiting (62)
Regulatory (19557)
Research institute (1314)
Resumes & cover letters (332)
South America (1052)
Southern California (700)
Startups (3853)
Texas (240)
United States (8204)
Vaccines (441)
Washington State (263)
Weight loss (125)
Date
Today (128)
Last 7 days (589)
Last 30 days (2194)
Last 365 days (37676)
2024 (25925)
2023 (40262)
2022 (50449)
2021 (53660)
2020 (50728)
2019 (42165)
2018 (32210)
2017 (32386)
2016 (30646)
2015 (36058)
2014 (28701)
2013 (23602)
2012 (25172)
2011 (25363)
2010 (23245)
627,380 Results for "ert parent company".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
Duchenne UK and Parent Project Muscular Dystrophy Award $500,000 to Evaluate Safety and Tolerability of Muscle Progenitor Cells in Phase 1 Trial
Parent Project Muscular Dystrophy (PPMD), a US nonprofit organization, and the UK charity Duchenne UK, two leading organizations dedicated to ending Duchenne muscular dystrophy (Duchenne), are excited to announce the recipient of their Joint Call for Therapeutic Projects.
April 23, 2024
·
5 min read
Policy
Ikerian (parent company of RetinAI U.S. Inc.) receives EU-MDR Certificate for four devices, its Ophthalmology Data Platform and AI models
Ikerian AG (“Ikerian”) a leader in developing software solutions for medical image and data management and artificial intelligence (AI) in healthcare, today announced the registration as Class IIa medical devices under the European Union Medical Device Regulation (Regulation (EU) 2017/745) (EU-MDR) of 4 devices.
June 24, 2024
·
3 min read
Business
Immunology Based Suicide Prevention Company Campbell Neurosciences Announces Appointment of Public Company Veteran Raymond Oliver as Chairman of the Board
Therapeutic Solutions International, Inc. (TSOI) Pre-Spin-Off Company Plans to Enter Capital Markets Through Partial Distribution of its Shares to Shareholders of Parent Company.
May 9, 2024
·
4 min read
Satellos Announces Presentation at Parent Project Muscular Dystrophy (PPMD) 30th Annual Conference
Satellos Bioscience Inc. today announced that Frank Gleeson, Satellos CEO, will join leading members of the Duchenne medical and scientific community during a panel discussion at PPMD’s 30th Annual Conference being held from June 27–29, 2024 in Orlando, Florida.
June 27, 2024
·
7 min read
Ikerian AG, Parent Company of RetinAI U.S. Inc. Announces Final Close of USD 6.18M (CHF 5.65M) Series A Extension Financing
Ikerian AG and its subsidiary, RetinAI U.S. Inc. a leading developer of software solutions for medical image and data management
May 2, 2024
·
7 min read
Biotech Beach
Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar to Review Latest Developments of CAP-1002 Program
Capricor Therapeutics announced that the Company will host a webinar with the nonprofit organization Parent Project Muscular Dystrophy to review key regulatory details and provide clinical updates that support the advancement of its ongoing HOPE-3, Phase 3 clinical trial of CAP-1002 for treating Duchenne muscular dystrophy.
October 19, 2023
·
4 min read
Employer Resources
How to Support Working Parents Without Alienating Child-Free Staff
Providing extra benefits and perks to parents in the workplace can be polarizing, but it doesn’t have to be.
June 28, 2023
·
4 min read
·
Rosemary Scott
Hansa Biopharma AB recognizes a write-up of SEK 1.430 billion in intangible assets related to Idefirix in the financial statements of the parent company - no impact on the consolidated financials
Hansa Biopharma AB announces that, in accordance with chapter 4, 6§ of the Swedish Annual Accounts Act and RFR 2, it has elected to recognize a write-up of SEK 1.430 billion in intangible assets in the statutory financial statements of the parent company Hansa Biopharma AB.
July 4, 2023
·
2 min read
Business
Genentech Shutters Cancer Immunology Group Amid Wider R&D Reprioritization
The unit’s closure comes as Genentech’s parent Roche rethinks its cancer business, an effort that has included the discontinuation of three early-stage candidates and a T-cell partnership with Adaptimmune.
August 19, 2024
·
2 min read
·
Tristan Manalac
Pharm Country
Parent Assist Link Solutions Announces a Revolutionary Digital Awareness Tools EIVA for Early Childhood Intervention Unveiled
Today, Parent Assist Link Solutions proudly introduce the company’s groundbreaking software product, designed exclusively for early childhood intervention (0-5 years), marking a significant milestone in the field.
July 7, 2023
·
2 min read
1 of 62,738
Next
